Oculocutaneous Albinism
📧 Sign up to get email alerts when something new happens for Oculocutaneous Albinism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Vision Response to Dopamine Replacement [Phase 2]
Phase 2 trial update for vision response to dopamine replacement in albinism conditions; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Nitisinone for Type 1B Oculocutaneous Albinism [Phase 1, Phase 2]
Clinical trial update for nitisinone in Type 1B oculocutaneous albinism (Phase 1/2) completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome [Phase 1, Phase 2]
This clinical trial evaluated a multi-drug regimen for severe pulmonary fibrosis in Hermansky-Pudlak Syndrome (a rare genetic disorder); the…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome [Phase 2]
Phase 2 trial of oral pirfenidone for Hermansky-Pudlak syndrome-associated pulmonary fibrosis has completed and results have been posted. Th…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Visual Function and Ocular Pigmentation in Albinism
A completed NEI-sponsored clinical trial evaluated visual function and ocular pigmentation in individuals with albinism.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.